The role of postmortem studies in pneumonia etiology research. by Turner, Gareth DH et al.
Turner, GD; Bunthi, C; Wonodi, CB; Morpeth, SC; Molyneux, CS;
Zaki, SR; Levine, OS; Murdoch, DR; Scott, JA (2012) The role of
postmortem studies in pneumonia etiology research. Clinical infec-
tious diseases , 54 Suppl 2. S165-71. ISSN 1058-4838 DOI: 10.1093/cid/cir1062
Downloaded from: http://researchonline.lshtm.ac.uk/967466/
DOI: 10.1093/cid/cir1062
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
S U P P L E M E N T A R T I C L E
The Role of Postmortem Studies in Pneumonia
Etiology Research
Gareth D. H. Turner,1,8 Charatdao Bunthi,2 Chizoba B. Wonodi,3 Susan C. Morpeth,4,8 Catherine S. Molyneux,4
Sherif R. Zaki,5 Orin S. Levine,3 David R. Murdoch,6,7 and J. Anthony G. Scott4,8
1Mahidol-Oxford Research Unit, and Department of Tropical Pathology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;
2International Emerging Infections Program, Thailand Ministry of Public Health-U.S. Centers for Disease Control and Prevention Collaboration,
Nonthaburi; 3PERCH Study group, The Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Hospital, Baltimore, Maryland;
4KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya; 5Division of Pathology, Centers for Disease Control and Prevention, Atlanta,
Georgia; and 6Department of Pathology, University of Otago, and 7Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand;
and 8Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom
The diagnosis of etiology in severe pneumonia remains a challenging area. Postmortem lung tissue potentially
increases the sensitivity of investigations for identification of causative pathogens in fatal cases of pneumonia
and can confirm antemortem microbiological diagnoses. Tissue sampling allows assessment of histological
patterns of disease and ancillary immunohistochemical or molecular diagnostic techniques. It may also
enhance the recognition of noninfectious conditions that clinically simulate acute pneumonia. Biobanking of
lung tissue or postmortem culture isolates offers opportunities for new pathogen discovery and research into
host-pathogen interactions. The Pneumonia Etiology Research for Child Health study proposes a percutaneous
needle biopsy approach to obtain postmortem samples, rather than a full open autopsy. This has the advantage
of greater acceptability to relatives, but risks greater sampling error. Both approaches may be susceptible to
microbiological contamination or pathogen degradation. However, previous autopsy studies have confirmed
the value of histological examination in revealing unsuspected pathogens and influencing clinical guidelines
for the diagnosis and treatment of future pneumonia cases.
Pneumonia is the largest global infectious cause of
childhood mortality [1]. Our current understanding of
the causes of pneumonia is based on studies in the 1980s
that predated the global epidemic of human immuno-
deficiency virus (HIV)/AIDS and the introduction of
vaccines against two major causes of pyogenic bacterial
pneumonia, Haemophilus influenzae type b and Strepto-
coccus pneumoniae. These two organisms are estimated
to cause up to 50% of severe pneumonia in Africa, so
effective vaccination programs would lead to a higher
proportion of pneumonia caused by other pathogens,
with implications for optimal treatment strategies [2].
The Pneumonia Etiology Research for Child Health
(PERCH) project is a large prospective multicentre case
control study that aims to address the changing etiology
of severe pneumonia in children. It also provides an
opportunity to study the pathology of fatal pneumonia.
Although postmortem diagnostics will not reveal the
causes of fatal pneumonia in all cases, the relevant in-
formation obtained will help to prevent deaths from
pneumonia in the future by identifying pathogens found
in children with fatal illness.
The identification of pathogens that cause pneumo-
nia during life is limited by several factors [3]. First, it is
difficult to obtain tissue specimens from the infection
site in the lung. At present, pneumonia diagnosis relies
on the assessment of clinical samples such as blood or
sputum using standard culture-based microbiological
techniques. Additional samples are likely to be more
representative of the diseased area, such as induced
sputum, bronchoscopic lower respiratory tract wash-
ings or direct lung needle aspirates. Frequently, none of
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these antemortem specimens are able to be collected from
cases of very severe pneumonia in which the patients die
during or soon after admission, leaving an important gap in
our knowledge of the causes of fatal pneumonia. A second
factor that introduces complications into the microbiological
workup of pneumonia is the large number of organisms
(which may or may not be pathogenic) inhabiting the upper
respiratory tract, which is often the site of sampling in chil-
dren with pneumonia. For example, S. pneumoniae, the most
common global cause of bacterial pneumonia in children, is
also carried in the nasopharynx of the majority of children
.5 years of age [4]. This lowers the specificity of PCR tests or
other tests that are conducted on samples such as sputum or
nasopharyngeal culture that originate from or pass through
the upper respiratory tract.
Standard clinical and laboratory diagnostics will therefore
fail to identify a causative pathogen in a significant proportion
of cases of pneumonia. Postmortem examination of fatal pneu-
monia cases can increase the overall proportion of cases with
a definitive diagnosis, and importantly, provide information that
increases our understanding of the causes of fatal pneumonia.
Autopsy data are usually difficult to obtain in research studies
because of acceptability to relatives, approval by ethical review
boards and logistics. The PERCH project offers a rare and valu-
able opportunity to obtain postmortem data to match compre-
hensive antemortem microbiological testing in the same patients.
The investigators have therefore planned to undertake such
a study, taking into account previously published data, the need
to maximize recruitment in order to collect useful information,
and the problems of autopsy studies in general. The aims of
this study are summarized in Supplementary Table 1.
THE AIMS OF AUTOPSY STUDIES IN FATAL
PNEUMONIA
Establishing a Diagnosis
The etiology of severe pneumonia in patients who arrive at the
hospital in extremis and die shortly after arrival may remain
unknown, as there may be no time to take appropriate samples.
Where antemortem microbiology fails or is unavailable, an au-
topsy may allow a definitive diagnosis of the causative pathogen
either through culture or histology. For example, retrospective
autopsy studies have been used to identify both adenovirus and
Mycoplasma pneumoniae as important pathogens causing pedi-
atric fatal pneumonia in China [5, 6].
The most comprehensive postmortem study of the etiology
of respiratory illness was conducted in 264 fatal pediatric cases
in Zambia [7]. The most common causes of death were pyogenic
bacterial pneumonia (44%), Pneumocystis jirovecii pneumonia
(PCP, 22%), cytomegalovirus pneumonia (16%) and pulmonary
tuberculosis (20%), and there was a high prevalence of dual
infections (48% in HIV-positive cases and 33% in HIV-
negative cases). These diagnoses were made for both HIV-
positive and HIV-negative groups, but surprising findings
included the high prevalence of PCP and pulmonary tubercu-
losis in HIV-negative patients, and the substantial proportion
(18%) of HIV-negative patients with lymphocytic pneumonitis
but no specific pathogen histologically. The authors concluded
that autopsy represented the best way of obtaining accurate
etiological data on the causes for pneumonia.
One potential problem with either histological or micro-
biological diagnosis is that finding an organism (especially in
a mixed infection) does not mean it is the direct cause of
disease or death. For instance, a major cause of death in in-
fluenza pandemics is secondary pyogenic bacterial pneumonia
[8]. However, a dual approach, where the histological pattern
of disease can be linked to the microbiological results, would
strengthen the attribution of causality. No study has yet sys-
tematically compared the histological findings with antemor-
tem or postmortem microbiology.
An etiological diagnosis of pneumonia can be made using
histology, where pathogens are indicated by characteristic tissue
changes such as granulomatous inflammation in tuberculosis
or viral inclusion bodies; specific organisms can be identified
using morphology and histochemical or immunohistochemical
staining. In addition, autopsy can reveal lung conditions that
clinically simulate acute infectious pneumonia, such as malaria,
lymphocytic interstitial pneumonia (LIP), noninfectious pneu-
monia (due to aspiration) or acute heart failure. Infections may
produce ‘‘final common pathway’’ appearances in the lung, such
as consolidative pneumonia, interstitial inflammation, or diffuse
alveolar damage, which are not specific to a particular pathogen.
However, the diagnostic sensitivity of autopsy tissue can be
increased by the use of special stains (such as Gram, Giemsa,
Ziehl-Neelsen or silver stains), immunohistochemistry or
molecular pathology techniques to identify pathogens.
The diagnosis of pulmonary tuberculosis is important, be-
cause it is treatable, contagious and may contribute to a fatal
outcome, but it can also be difficult, especially in HIV-infected
children [9–12]. Typically, tuberculosis is diagnosed antemor-
tem on the basis of clinical and radiological findings, but these
features are often shared with other opportunistic infections,
reducing their specificity in diagnosis. The Zambia autopsy
study demonstrated a high prevalence of pulmonary tuber-
culosis in both HIV-positive and HIV-negative patients [7].
However, in another study of 93 HIV-infected children in
South Africa, Rennert et al confirmed the diagnosis of tubercu-
losis from lung tissue in only 4% of the patients [13]. Among
patients who had been on empiric treatment for tuberculosis
before death, some 18% had no postmortem evidence of active
disease in the lung. This disparity may have been due to effective
treatment or could indicate clinical misdiagnoses because other
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pathogens, specifically cytomegalovirus and P. jirovecii, were
found at autopsy. Histological evaluation of lung tissue will
improve diagnosis and provide quality assurance of antemor-
tem diagnosis, as well as establish the prevalence of tubercu-
losis in different populations.
Validation of Antemortem Microbiological Diagnosis
Data from autopsies can help to validate new and existing an-
temortem diagnostic methods. Some lung infections, particu-
larly those caused by fungi or viruses, are difficult to diagnose
even given optimal antemortem diagnostics due to a lack of
specific clinical features or the fastidious nature of their
growth in culture. A study of invasive pulmonary aspergillosis
in Switzerland found that 38% of cases in non-neutropenic
patients (n 5 67) were recognized only at autopsy [14]. Not
only does autopsy increase the sensitivity of a study to detect
the underlying infection, but the increased specificity of
postmortem examination also leads to a more accurate esti-
mate of the contribution of major pathogens to pneumonia
etiology.
Tissue samples also have the advantage of allowing ancillary
diagnostic tests. A study on influenza A H1N1 deaths in the US
showed that testing autopsy lung tissue using PCR and immu-
nochemistry assays identified many bacterial lung infections
missed by standard clinical methods [15]. Immunohistochem-
istry for specific common bacterial pathogens has been used
on lung tissues to identify S. pneumoniae [16], H. influenzae or
Staphylococcus aureus, and viruses such as respiratory syncytial
virus and influenza [17]. In situ or extraction PCR techniques
from frozen or formalin fixed, paraffin-embedded tissues can
also be used for ancillary molecular diagnostic tests that will
identify viral and fungal pathogens [18, 19]. Molecular analyses
of clinical samples using a variety of techniques are increasingly
used in diagnostic practice [20]. Pathogen identification by 16s
rRNA sequencing [21] or viral diagnostics using multiplex PCR
on postmortem samples can also be used to establish a cause
of death or validate antemortem diagnosis. However, such
methods are beyond the scope of routine laboratories, and
are not yet validated against standard microbiological tests.
The PERCH project offers a unique opportunity for com-
parative antemortem and postmortem diagnostic correlation
in a clinically well-characterized and geographically diverse
patient group.
Forming a Bioresource for Future Research
Samples from an autopsy study form a valuable potential
resource for further investigation of both the host and
pathogen, which may influence disease susceptibility or
outcome in individual cases. Using host mRNA transcripts
extracted from lung tissue for microarray analysis or se-
quencing allows investigation of host responses and patho-
genic mechanisms within the lung, as has been validated for
transcriptomic studies of lung tumors and interstitial lung
disease [22–24]. High throughput genomic, proteomic, mi-
croRNA or siRNA screening technologies have been pro-
posed as a way of using systems biology to increase our
understanding of the interaction between pathogens and the
host response [25, 26].
Postmortem culture isolates may contain a mixed bacterial
flora, some of which may be difficult to grow using standard
culture methods or may be overgrown by other bacteria. 16S
rRNA pathogen sequencing may allow the detection of more
fastidious organisms, and in combination with control samples
from the unaffected lung, allow differentiation from back-
ground postmortem contaminants [21]. The opportunity to
biobank pathogens from postmortem cultures, in addition
to antemortem isolates, should aid the rapid sequencing of
entire genomes from multiple strains of a pathogen. This will
aid vaccine design and the study of transmission, antibiotic re-
sistance and virulence factors in individual pathogens, such
as the development of multidrug resistance in S. pneumoniae,
or immune escape following the introduction of the pneu-
mococcal vaccine [27].
Novel Pathogen Discovery
Another potential use of postmortem samples is the search for
novel pathogens [28]. It is difficult to attribute causation in
pathogen discovery projects that do not have supporting
histopathology studies. New pathogenic agents from autopsy
samples can be thoroughly described and correlated clinico-
pathologically, as was done with hantavirus infection or in-
fluenza A H1N1 [29–31], and the likelihood of their role in the
etiology and pathogenesis of pneumonia can be determined.
The PERCH project aims to collect postmortem tissue bi-
opsies from clinically well-defined, fatal pneumonia cases in
a number of different centers and link them to high quality
clinical, radiological and antemortem diagnostic information,
which will represent a unique and valuable resource for future
research into pneumonia etiology.
DRAWBACKS TO AUTOPSY STUDIES
There are several potential problems with autopsy studies.
First is the inherent bias in autopsy data due to the selection of
fatal cases. Surviving cases may have a different, less patho-
genic etiology. Second, patterns of consent ensure that pa-
thology is only studied in a proportion of fatal cases, which
may introduce bias if a particular pathogen is common in
a group where autopsy was unacceptable for religious or
cultural reasons. Additional problems include microbiolog-
ical contamination of postmortem tissue and lack of de-
tection sensitivity due to the fastidiousness of a pathogen
or choice of diagnostic test.
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ETHICAL ISSUES IN AUTOPSY TRIALS
Giving consent for an autopsy is difficult for a grieving relative.
For some families, the desire to know the cause of death or the
altruistic recognition of the value of studies for future patients
may outweigh any objections to autopsy. Factors adversely
influencing consent include any reluctance of the staff to ask pa-
rents for consent, religious or cultural objections, concerns about
mutilation of the body, interference with burial arrangements, the
perception that the procedure is of no benefit to the patient or
a lack of interest in the study rationale [32, 33]. Initial and careful
consultation with key stakeholders in the potential research
setting should help identify the range and depth of sensitivities,
and if and how to proceed. This will depend on the study planned;
for instance, the process of gaining consent for a lung aspirate
during life, which is less invasive and may provide diagnostic
information of value in treating that individual, would be very
different as compared to asking for a postmortem sample, and
would require a different ethical approval and consent process.
It is preferable to obtain the relatives’ consent only after the
death of a patient, as preemptive consent can give rise to per-
ceived issues of conflict of interest. However, this timeline in-
troduces the risk of consent refusal at a time of great emotional
stress. Obtaining consent requires sensitivity and training, and
should be done by local clinicians or nurses who are familiar
with the aims of the study in order to reduce language difficulties
and explain the study rationale clearly. Ideally, they would be
trained counselors who would be able to adequately deal with
their own emotions and those of the parents, as well as answer all
questions and establish a personal link for parents so that they
could come back and talk in the future if they wish. This would
involve prestudy training that utilizes protocols, enacts scenarios,
and involves mentoring by senior staff, with the goal of gaining
experience in asking for consent in a research study setting, to
avoid coercion and exacerbating distress. The results of an in-
dividual autopsy should be made available to parents, and the
results of the study should be disseminated to health pro-
fessionals and the local community, in order to validate the
reasons for doing it and to demonstrate how this information
may change the management of future patients with pneumonia.
In general, close engagement with the local community is key
for the consenting process, because the centers that are capable
of performing autopsy studies are often involved in multiple
projects, and the introduction of a new, unfamiliar autopsy-
based project could threaten participation in other studies.
METHODS FOR AUTOPSY EXAMINATION OF
PNEUMONIA ETIOLOGY
Given the constraints of open autopsy examination, less invasive
methods of postmortem examination of the lung would be
extremely helpful, and would enable a trained clinical staff
member who is not an expert pathologist to perform the bi-
opsies. We considered two such approaches: postmortem lung
aspirates and percutaneous needle lung biopsy. These offer
a simpler and less invasive way to obtain lung samples for
microbiology and histology.
There are several potential problems with the use of biopsy
tissues derived from autopsy studies, including sampling
error, sample preservation and contamination. Obtaining
tissue directly from the diseased area is easier in open au-
topsy. Percutaneous sampling methods risk missing areas
of pathology, so it is important to correlate antemortem
clinical examinations and radiographs when obtaining a tis-
sue sample of the affected area. Several pathogens, such as
S. pneumoniae, are highly temperature sensitive and are de-
stroyed by refrigeration (sometimes used to preserve bodies
before autopsy), whereas desiccation of a specimen prior to
microbiological testing can destroy viral pathogens. Close
cooperation is required between the pathologist and micro-
biologist to process post mortem microbiological samples as
rapidly as possible. This presents problems if consent for
sampling is delayed and if laboratories are distant from the
site of the biopsy.
A criticism commonly leveled at postmortem microbiological
testing is the issue of contamination. In the immediate peri-
mortem period, widespread cellular degradation and break-
down in physiological barriers begins (such as in the large
bowel), which is associated with the translocation of a mixed
flora of intestinal bacteria into the bloodstream and contami-
nation of tissues. Resuscitation attempts may exacerbate con-
tamination from the upper respiratory tract. Sampling lung
tissue quickly after death would reduce the risk of postmortem
bacterial invasion, but would not prevent agonal changes. Con-
taminating organisms can multiply during the interval between
death and sampling, obscuring a true pathogen.
Postmortem microbiological studies of children who died
from Sudden Unexplained Death in Infancy have shown that
the translocation of bacteria across mucosal membranes does
not lead to an increased probability of a positive postmortem
bacterial culture, nor of polymicrobial cultures. Indeed, posi-
tivity rates decrease with a postmortem interval of 2 days,
probably due to death of the organisms [34]. However, a pro-
portion of postmortem microbiological diagnoses will be un-
interpretable due to contamination, and success requires
sterile technique [35] and choosing the appropriate culture
method (such as with fungal pathogens or M. tuberculosis)
that may not be a first line microbiological test. The ability of
an autopsy examination to distinguish between a positive
microbiological result representing contamination or a truly
causative organism will increase if a result can be compared
with antemortem samples, or concurrent histology.
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Needle Lung Aspirates
Much of the data on pneumonia etiology upon which our
current understanding of the field is based are derived from
clinical studies utilizing lung aspirates on living patients. Pre-
vious studies have proven the increased sensitivity of needle lung
aspirates in living patients [36], and have described their use for
postmortem microbiological testing [37]. A needle lung aspirate
would offer the simplest way of gaining access to local diseased
tissue, without scarring or the need for specialist training or
facilities. However, this approach would not provide tissue
samples that could be histologically analyzed.
Percutaneous Needle Biopsy
This offers several potential advantages to open autopsy. It
allows tissue collection for microbiological and histopatho-
logical diagnosis with ancillary approaches as described above.
Taking a biopsy confined to the lung may also allay some
concerns regarding consent, as it is rapid, will not delay burial
arrangements, is minimally invasive and leaves little mark on
the body. The principal disadvantage of this approach is
sampling error. Studies of needle biopsy as an alternative to
open autopsy have reported variable success, and depending
on the organ sampled, the success rate can be as low as 50%
of the total biopsies. Sampling error can lead to disparities
between the resultant tissue diagnoses compared with an open
autopsy [38–40]. If multiple biopsy sites are used, then the
sampling of other tissues such as the spleen or body fluids
such as CSF or urine can be performed, which may increase
the value of a microbiological diagnosis on the lung biopsy
tissue, without requiring open autopsy.
Open Autopsy
Examples of successful postmortem studies from countries
such as Zambia [7] and the Ivory Coast [41] confirm the
practical feasibility of doing open autopsy studies on pneu-
monia. However, their principal disadvantage is low consent
rates; for example, only 25% of families approached in
Lusaka consented to open autopsy following the death of
their child [7]. They also depend on finding experienced
pathologists at the study sites who can examine autopsy
material adequately, with appropriate laboratory, microbi-
ological and clinical support.
FORMULATING THE DESIGN OF A
POSTMORTEM PERCUTANEOUS NEEDLE
BIOPSY STUDY
The inclusion of an autopsy study within PERCH highlighted
the dilemma of antemortem studies that are inherently limited
and full autopsy studies that are impracticable in many of the
study sites. We therefore propose that a postmortem percuta-
neous needle biopsy study should be included in the PERCH
project. A biopsy approach offers greater practical utility in
study centers where resources are limited and consent rates
make it unrealistic to perform an open autopsy study. Some of
the potential advantages and disadvantages of this plan are
shown in Supplementary Table 2.
To offset the issues of sampling error inherent in a biopsy
approach, we will increase the anatomical representativeness
by taking multiple biopsies from both lungs through the
same entry site on each side. If antemortem clinical or ra-
diological findings indicate lobar pneumonia, then we will
biopsy the diseased area preferentially, but will collect con-
trol, uninfected tissue from the contralateral lung as a base-
line to interpret polymicrobial contaminating growth in
subsequent cultures. However, in diffuse or multifocal dis-
ease, we will take biopsies from all lobes to minimize sam-
pling error. If no antemortem localization of disease is
available, then the case will be sampled with the protocol
outlined in Supplementary Figure 1.
We plan to use the resulting biopsies for histological and
microbiological testing and preserve other biopsies in specific
fixatives to allow further ancillary diagnostic tests (Supple-
mentary Figure 2), including mRNA or DNA extraction for
molecular pathology studies and pathogen 16s rRNA typing.
Frozen tissue will also be preserved, as this is superior to formalin-
fixed tissues for subsequent immunohistochemistry and molec-
ular pathology [18].
CONCLUSIONS
The diagnosis of the cause of fatal pneumonia is important in
identifying new pathogens and guiding treatment and preven-
tion strategies in the postvaccine era. The inclusion of post-
mortem examinations can enhance the fulfillment of these
objectives in studies of pneumonia etiology. Antemortem testing
of blood and upper respiratory tract samples can be difficult and
lacks sensitivity and specificity. Examination of diseased lung
tissue postmortem offers the chance to establish a diagnosis if
it is unknown, or confirm an uncertain antemortem diagnosis.
Histological examination can identify specific pathogens, can
corroborate a microbiological diagnosis, and may often reveal
unexpected infective etiologies. It is likely that new pathogens
will be discovered from the pathology tissue, leading to research
into host responses that will justify the difficulties involved in
performing autopsies in challenging environments. Compara-
tive studies are needed to measure the effectiveness of less in-
vasive procedures such as needle aspiration and biopsy with
the ‘‘gold standard’’ of open autopsy. A percutaneous needle
lung biopsy postmortem study based within the PERCH
project has been designed to improve the diagnosis of eti-
ology in severe pneumonia and provide evidence to influence
treatment and prevention programs in the future.
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